Traditional Chinese medicine compound preparation for treating cold, influenza and upper respiratory tract infection

Abstract

The invention relates to a traditional Chinese medicine compound preparation for treating cold, influenza and upper respiratory tract infection and a preparation method thereof. The traditional Chinese medicine compound preparation comprises the following active ingredients in percentage by weight: 10 to 15 percent of honeysuckle, 15 to 20 percent of radix puerariae, 10 to 15 percent of baikal skullcap root, 10 to 15 percent of radix isatidis, 10 to 15 percent of radix bupleuri, 10 to 15 percent of forsythia, 8 to 12 percent of cyrtomium fortunei, 5 to 8 percent of angelica dahurica and 5 to 8 percent of balloon flower. The preparation is in forms of granules, capsules, tablets and the like, has the functions of dispelling pathogenic wind from muscles, clearing away heat and toxic materials and relieving sore throat and a cough, and mainly treats symptoms such as fever, typhoid, body pain, snuffles, nose running, dry throat, pharyngalgia, cough, skin eruption, swelling and ulcer and the like caused by affection of exogenous wind-heat, cold and lung and stomach heat. The traditional Chinese medicine compound preparation has obvious treatment effect, fewer side effects, no damages to the liver and the kidney, and fragrant and sweet taste, children like to take the preparation and the preparation can be applied to the treatment of virus infection and the bacterial infection of children.

Description

technical field [0001] The invention relates to a traditional Chinese medicine preparation and a preparation method, in particular to an antibacterial and antiviral traditional Chinese medicine compound preparation and a preparation method. Background technique [0002] Influenza is an acute respiratory infectious disease caused by influenza virus. In history, there have been many worldwide influenza pandemics, among which the influenza epidemic in 1918 was the most serious, and its death toll reached more than 20 million, and most of the deaths were young adults aged 15-45. At present, the threat of influenza still exists. In early 2009, H1N1 influenza was discovered in South America and has spread to five continents around the world. As of July last year, a total of 2,003 confirmed cases of H1N1 influenza have been reported in mainland my country, and there is an increasing trend. WHO started the influenza program as early as 1948, and has established 111 national resear...

AI Technical Summary

Problems solved by technology

3. Vaccines are an important measure to prevent viruses. In recent years, they have developed rapidly, such as live vaccines, inactivated vaccines, nucleic acid vaccines, etc., but their effects are not satisfactory at present. The reason is that the influenza antigens continue to mutate, and the vaccines fail.

But so far, the research on the pharmacological effects of Chinese patent medicines for preventing and treating influenza still stays in anti-inflammatory, antipyretic, analgesic, improving clinical symptoms, etc., and there are not many studies on the pharmacological effects of upper respiratory viruses. There is a need for new Chinese patent medicines for influenza that can improve symptoms and resist upper respiratory viruses